Literature DB >> 10883019

Current management of epithelial ovarian carcinoma: a review.

D E Marsden1, M Friedlander, N F Hacker.   

Abstract

Epithelial carcinoma of the ovary is the most lethal of gynaecological malignancies and it affects about one in 70 women in developed countries. Over 75% of women with the disease have tumour spread beyond the pelvis at the time of diagnosis, and their treatment requires the appropriate use of surgery and chemotherapy. The strategies used in the treatment of ovarian cancer are constantly evolving. An overview of current treatment regimens and their evolution is provided, with particular emphasis on the interdependence of surgery and chemotherapy in the optimal management of the disease. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10883019     DOI: 10.1002/1098-2388(200007/08)19:1<11::aid-ssu3>3.0.co;2-3

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  22 in total

1.  Uterine metastases in ovarian carcinoma: frequency and survival in women who underwent hysterectomy.

Authors:  Joseph Menczer; Angela Chetrit; Siegal Sadetzki
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  Cytosolic phospholipase A2 as a molecular target for the radiosensitization of ovarian cancer.

Authors:  Rachael R Schulte; Amanda G Linkous; Dennis E Hallahan; Eugenia M Yazlovitskaya
Journal:  Cancer Lett       Date:  2011-05-28       Impact factor: 8.679

3.  HER2-positive mucinous adenocarcinomas of the ovary have an expansile invasive pattern associated with a favorable prognosis.

Authors:  Sang Kyum Kim; Nam Hoon Cho
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

4.  Paeonol enhances the sensitivity of human ovarian cancer cells to radiotherapy-induced apoptosis due to downregulation of the phosphatidylinositol-3-kinase/Akt/phosphatase and tensin homolog pathway and inhibition of vascular endothelial growth factor.

Authors:  Hai-Mei Zhou; Qin-Xiang Sun; Yan Cheng
Journal:  Exp Ther Med       Date:  2017-08-03       Impact factor: 2.447

5.  Secondary appendiceal tumors: a review of 139 cases.

Authors:  Won Jae Yoon; Yong Bum Yoon; Youn Joo Kim; Ji Kon Ryu; Yong-Tae Kim
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

6.  Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival?

Authors:  Joseph Menczer; Irena Usviatzov; Erez Ben-Shem; Abraham Golan; Tally Levy
Journal:  J Gynecol Oncol       Date:  2011-09-28       Impact factor: 4.401

7.  TC-1 (C8orf4) expression is correlated with differentiation in ovarian carcinomas and might distinguish metastatic ovarian from metastatic colorectal carcinomas.

Authors:  Hong-Tao Xu; Yang Liu; Shu-Li Liu; Yuan Miao; Qing-Chang Li; En-Hua Wang
Journal:  Virchows Arch       Date:  2013-02-02       Impact factor: 4.064

8.  MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.

Authors:  Eun Ji Nam; Maria Lee; Ga Won Yim; Jae Hoon Kim; Sunghoon Kim; Sang Wun Kim; Young Tae Kim
Journal:  BMC Med Genomics       Date:  2012-05-29       Impact factor: 3.063

9.  Monitoring physical and psychosocial symptom trajectories in ovarian cancer patients receiving chemotherapy.

Authors:  Verena Meraner; Eva-Maria Gamper; Anna Grahmann; Johannes M Giesinger; Petra Wiesbauer; Monika Sztankay; Alain G Zeimet; Barbara Sperner-Unterweger; Bernhard Holzner
Journal:  BMC Cancer       Date:  2012-02-28       Impact factor: 4.430

10.  Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.

Authors:  K Oikonomopoulou; L Li; Y Zheng; I Simon; R L Wolfert; D Valik; M Nekulova; M Simickova; T Frgala; E P Diamandis
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.